Abstract
Peroxisomal disorders represent a recently recognized group of inherited diseases in man, now comprising 14 different disorders. If discussion is restricted to those peroxisomal disorders in which there is neurological involvement (thereby excluding hyperoxaluria and acatalasaemia), results over the least few years have shown that analysis of very-long-chain fatty acids (VLCFAs) is a highly reliable initial test to establish whether or not one is dealing with a peroxisomal disorder. Rhizomelic chondrodysplasia punctata, its recently identified variant form and glutaryl-CoA oxidase deficiency will show no abnormalities and must be identified by other means. Recently we have found a few clinically proven cases of adrenoleukodystrophy showing normal VLCFA in plasma but clearly abnormal values in fibroblasts. This suggests that great care is warranted in interpreting plasma VLCFA analyses. Furthermore, plasma bile acids, phytanic acid, pristanic acid and pipecolic acid should be analysed in any patient with clinical symptoms suggestive for a peroxisomal disorder but normal plasma VLCFAs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- alkyl DHAP :
-
synthase alkyldihydroxyacetonephosphate synthase
- DHAPAT :
-
dihydroxyacetonephosphate acyltransferase
- IRD :
-
infantile Refsum disease
- NALD :
-
neonatal adrenoleukodystrophy
- PAF :
-
platelet activating factor
- RCDP :
-
rhizomelic chondrodysplasia punctata
- VLCFA :
-
very-long-chain fatty acid
- X-ALD :
-
X-linked adrenoleukodystrophy
- ZS :
-
Zellweger syndrome
References
Bennett MJ, Pollitt RJ, Hale DE, Goodman SI, Vamecq J (1991) Atypical riboflavin-responsive glutaric aciduria, and deficient peroxisomal glutaryl-CoA oxidase activity: a new peroxisomal disorder. J Inherited Metab Dis 14:165–173
Danpure C (1989) Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type I. J Inherited Metab Dis 13:363–366
Kelley RI, Datta NS, Dobijns WS, Hajra AK, Moser AB, Noetzel MJ, Zackai EH, Moser HW (1986) Neonatal adrenoleukodystrophy: new cases, biochemical studies and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet 23:869–901
Lazarow PB, Moser HW (1989) Disorders in peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1479–1509
Monnens LAH, Heymans HSA (1987) Peroxisomal disorders: clinical characteristics. J Inherited Metab Dis 10 [Suppl]:23–32
Moser HW, Moser AB (1989) X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1511–1532
Moser HW, Moser AB (1991) Measurement of saturated very long chain fatty acids in plasma. In: Hommes FA (ed) Techniques in diagnostic human biochemical genetics. Wiley-Liss, New York, pp 177–191
Onkenhout W, Van der Poel PFH, Van den Heuvel MPM (1989) Improved determination of very-long-chain fatty acids in plasma and cultured skin fibroblasts: application to the diagnosis of peroxisomal disorders. J Chromatogr (Biomed Applic) 494:31–41
Poll-Thé BT, Saudubray JM, Ogier HAM, Odièvre M, Scotto JM, Monnens L, Govaerts LCP, Roels F, Cornelis A, Schutgens RBH, Wanders RJA, Schram AW, Tager JM (1987) Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy: Eur J Pediatr 146:477–483
Schutgens RBH, Schrakamp G, Wanders RJA, Heymans HSA, Tager JM, den Bosch H van (1989) Pre- and perinatal diagnosis of peroxisomal disorders. J Inherited Metab Dis 12:118–134
Smeitink JAM, Beemer FA, Espeel M, Donckerwolke RAMG, Jakobs C, Wanders RJA, Schutgens RBH, Roels F, Duran M, Dorland L, Berger R, Poll-Thé BT (1992) Bone dysplasia associated with phytanic acid accumulation and deficient plasmalogen biosynthesis: a peroxisomal entity amenable to plasmapheresis. J Inherited Metab Dis 15:377–380
Wanders RJA, Heymans HSA, Schutgens RBH, Barth PG, Bosch H van den, Tager JM (1988) Peroxisomal disorders in neurology. J Neurol Sci 88:1–39
Wanders RJA, Roermund CWT van, Schutgens RBH, Barth PG, Heymans HSA, Bosch H van den, Tager JM (1990) The inborn errors of peroxisomal β-oxidation. J Inherited Metab Dis 13:4–36
Wanders RJA, Roermund CWT van, Schelen A, Schutgens RBH, Zeman J, Kozich V, Hyanek J, Casteels M, Mannaerts GP (1991) Di- and trihydroxycholestanoic acidaemia in twin sisters. J Inherited Metab Dis 14:357–360
Wanders RJA, Roermund CWT van, Denis S, Schutgens RBH, Illst L, Tager JM (1992) Molecular analysis of disorders of peroxisomal β-oxidation. In: Coates P, Tanaka K (eds) New developments in fatty acid oxidation. Wiley-Liss, New York, pp 507–519
Wanders RJA, Roermund CWT van, Lageweg W, Jakobs BS, Schutgens RBH, Nijenhuis AA, Tager JM (1992) X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. J Inherited Metab Dis 15:634–644
Wanders RJA, Schumacher H, Heikoop J, Schutgens RBH, Tager JM (1992) Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder. J Inherited Metab Dis 15:389–391
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wanders, R.J.A., Barth, P.G., Schutgens, R.B.H. et al. Clinical and biochemical characteristics of peroxisomal disorders: an update. Eur J Pediatr 153 (Suppl 1), S44–S48 (1994). https://doi.org/10.1007/BF02138777
Issue Date:
DOI: https://doi.org/10.1007/BF02138777